Related Experiment Video
Updated: Dec 29, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
[Strategy and stopping smoking interventions in smokers with tuberculosis]
J Perriot1, M Underner2, G Peiffer3
1Dispensaire Emile Roux, Centre de Lutte antituberculeuse et de Tabacologie, Clermont-Ferrand, France.
Smoking significantly worsens tuberculosis outcomes and treatment adherence. Smoking cessation is crucial for controlling the tuberculosis epidemic and improving patient recovery, supported by global health organizations.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Tuberculosis (TB) and smoking are leading causes of global mortality.
- Tobacco smoke exacerbates Mycobacterium tuberculosis infection, increasing TB severity, drug resistance, and mortality.
- Smokers with TB exhibit poorer treatment compliance compared to non-smokers.
Purpose of the Study:
- To highlight the detrimental impact of smoking on tuberculosis.
- To emphasize the importance of smoking cessation in TB management and epidemic control.
- To advocate for integrated tuberculosis and tobacco control programs.
Main Methods:
- Literature review and synthesis of existing research on TB and smoking.
- Analysis of the relationship between smoking, TB incidence, and patient outcomes.
- Examination of WHO recommendations for TB and tobacco control.
Main Results:
- Smoking increases TB risk, severity, and mortality.
- Smokers with TB show reduced treatment adherence.
- Smoking cessation improves TB treatment outcomes and patient compliance.
- Integrated national programs are recommended for TB and tobacco control.
Conclusions:
- Smoking cessation is a vital strategy for TB epidemic control.
- Health professionals must actively support smokers with TB in quitting.
- Coordinated efforts between TB and tobacco control programs are essential for public health.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

